Krsnaa Diagnostics Limited — Investor Meet, 05-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Krsnaa Diagnostics Limited reported strong operational performance for Q2 FY '25, achieving a 20% year-over-year revenue growth, totaling ₹186 crores. The company continues to expand its diagnostic services, notably through strategic investments in oncology and cardiac care. Key developments include securing contracts in multiple states and a partnership with United Imaging to enhance diagnostic capabilities. Krsnaa's financials reveal robust growth, with a 49% increase in profit after tax, and it remains committed to improving its service quality and expanding its market reach.